06.23.16
Alleging violations of the Federal Trade Commission Act and the CAN-SPAM Act, the Federal Trade Commission filed suit in Florida federal court against a pair of individuals and their companies in connection with weight loss products they marketed.
Following a winning streak dating back to its 2007 win in Evanston,1 the Federal Trade Commission (FTC) has suffered two losses over the last month in two of its three pending hospital merger challenges.
06.22.16
In this newsletter, we examine what's new in media as it relates to the Chinese market with specific emphasis on VR, Hollywood, and the ongoing digital transition.
In its April 25, 2016 Medicaid managed care final rule, the Centers for Medicare and Medicaid Services (CMS) provides a revised framework for determining how managed care plans should be paid by state Medicaid programs.
06.21.16
A Washington federal court issued a mixed decision for Telephone Consumer Protection Act defendant Lyft recently by allowing the suit to move forward on state law claims, but ruling that the ride-sharing company could not be liable under the federal statute for an advertising campaign that allowed ...
Massachusetts releases $1.8 billion DSRIP program waiver for public comment; CMS awards $32 million in grants to enroll uninsured children in Medicaid/CHIP; and Wisconsin withdraws proposed changes to Medicaid long-term care.
06.17.16
Reflecting the nationwide trend of pay equity, a new bill under consideration by California legislators would extend the state's Fair Pay Act (FPA) to include protections for race and ethnicity.
06.16.16
In its April 25, 2016 Medicaid managed care final rule, the Centers for Medicare and Medicaid Services (CMS) addresses a core issue: how managed care plans should be paid by state Medicaid programs.
The makers of a dietary supplement touted to help users lose weight and aid with the symptoms of menopause settled with the Federal Trade Commission over charges that their claims were unsubstantiated and violated Section 5 of the Federal Trade Commission Act.
The recent suspension of Draymond James by the NBA compares very favorably with the NFL's suspension of Tom Brady, regardless of the correctness of the decisions.
